CREDIT AGRICOLE SA : European Central Bank approval of the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
85
CREDIT AGRICOLE SA : European Central Bank approval of the tender offers for perpetual notes announced on 17 March 2017

This document is not an offer to purchase the securities described herein or any other securities. Any such offer, if made, will be made by means of an offer document or invitation to tender that will include the detailed terms of the offer, and that may contain restrictions on the ability of certain investors in certain jurisdictions to tender certain of their securities. The offer will not be made in any jurisdiction where it would be unlawful to do so, or where such offer would require registration with or approval by any governmental body or stock exchange.

Montrouge 28 April 2017

European Central Bank approval of the tender offers for perpetual notes announced on 17 March 2017

____________________

Crédit Agricole S.A. announces that the European Central Bank has given its approval on 27 April 2017 for the intended tender offers described in the press release of 17 March 2017.

In that press release, Crédit Agricole S.A. announced its intention, subject to receipt of the required ECB approval, to launch tender offers targeting six series of outstanding perpetual notes (listed in Appendix 1).

Further information on the intended tender offers can be found in the 17 March 2017 press release.

Crédit Agricole S.A. intends to launch the intended tender offers before the end of June 2017, subject to market conditions.

Appendix 1 Additional Details on Notes subject to the contemplated Tender Offer

ISIN Currency Outstanding amount Coupon Next Call Date Step-Up (Y/N) Grandfathering Treatment*
USF22797FJ25 / US225313AA37 USD 889.9m 6.637% until May 31 2017 3 month USD Libor + 123.25bp thereafter May 2027 N Tier 1 until end- 2021
FR0010161026 EUR 371.2m EUR CMS 10Y +2.5bp (floored at 0% and capped at 7.75%) Febr 2018 N Tier 1 until end- 2021
USF22797FK97 / US225313AB10 USD 1,000m 8.375% until Oct. 2019, 3 month USD Libor + 6.982% thereafter Oct 2019 Y Tier 1 until Oct. 2019
FR0010814418 GBP 291m 8.125% until Oct. 2019, 3 month GBP Libor + 6.146% thereafter Oct 2019 Y Tier 1 until Oct. 2019
FR0010575654 GBP 171.8m 7.589% until Jan. 2020, 3 month GBP Libor + 3.550% thereafter Jan 2020 Y Tier 1 until Jan. 2020
FR0010814434 EUR 450m 7.875% until Oct. 2019, 3 month Euribor + 6.424% thereafter Oct 2019 Y Tier 1 until Oct. 2019
  • NB: Possible regulatory capital and/or TLAC/MREL treatment after 2021 unclear on the basis of current and planned draft regulation (based on Crédit Agricole S.A.'s understanding and interpretation of relevant regulatory texts currently in force in the EU and in France).

Forward-Looking Statements   This communication may contain forward-looking information and statements about Crédit Agricole S.A. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Forward-looking statements may be identified by the words "believe," "expect," "anticipate," "target" or similar expressions. Although Crédit Agricole S.A.'s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Crédit Agricole S.A., that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, but are not limited to, those discussed or identified in the annual reports and other filings with the French Autorité des marchés financiers made or to be made by Crédit Agricole S.A.. Crédit Agricole S.A. undertakes no obligation to publicly update its forward-looking statements, whether as a result of new information, future events, or otherwise .

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...d8923c3d11

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 4

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Waller Supports Fed's Strategic Interest Rate Adjustment

Updated Category News Views 141

Waller Backs Fed's Rate Adjustment Strategy In a recent conversation about the Federal Reserve's monetary policy, Board of Governors Member Christopher Waller provided insights into the FOMC's choice to cut interest rates by 50 basis points. This announcement drew considerable attention during an interview broadcasted on a well-known financial news channel. These remarks...

Continue Reading
BayCare Welcomes Lynnette A. Clinton as New Chief Information Officer

Updated Category News Views 268

BayCare Health System Welcomes Lynnette A. Clinton Lynnette A. Clinton has made a significant return to BayCare Health System, taking on the key role of Chief Information Officer (CIO). Having previously served as the vice president of applications, Clinton is recognized for her leadership skills and dedication to advancing healthcare technology. Leadership Role and...

Continue Reading
FLSmidth Announces Successful Share Buy-Back Transactions

Updated Category News Views 212

FLSmidth's Strategic Share Buy-Back Program FLSmidth & Co. A/S has embarked on a significant share buy-back initiative aimed at enhancing shareholder value and demonstrating confidence in its operational capabilities. The company, a leading supplier of technology and services to the global mining industry, announced a program that allows for the repurchase of shares up to...

Continue Reading
Patrick Industries Boosts Quarterly Dividend for Investors

Updated Category News Views 121

Patrick Industries Announces Dividend Increase Patrick Industries, Inc. (NASDAQ: PATK) recently revealed an increase in its quarterly cash dividend, a move that reflects the company's lasting commitment to its shareholders and the robustness of its operational model. This decision comes as part of the company's ongoing strategy to deliver rewarding returns to investors....

Continue Reading
Omega Healthcare: Leading the Way in Ambulatory RCM Services

Updated Category News Views 117

Omega Healthcare Celebrates Recognition in RCM Services Omega Healthcare has been honored with the prestigious 2026 Best in KLAS award, distinguishing itself as a top performer in Ambulatory RCM Services. With an outstanding overall performance score of 92.2, this recognition marks a significant milestone for the company, reflecting its commitment to delivering...

Continue Reading